Abstract
Cell therapy with autologous mesenchymal stromal cells (MSCs) in patients with spinal cord injury (SCI) is beginning, and the search for its better clinical application is an urgent need. We present a phase 2 clinical trial in patients with chronic SCI who received three intrathecal administrations of 100 x 106 MSCs and were followed for 10 months from the first administration. Efficacy analysis was performed on nine patients, and safety analysis was performed on 11 patients. Clinical scales, urodynamic, neurophysiological and neuroimaging studies were performed previous to treatment and at the end of the follow-up. The treatment was well-tolerated, without any adverse event related to MSC administration. Patients showed variable clinical improvement in sensitivity, motor power, spasms, spasticity, neuropathic pain, sexual function or sphincter dysfunction, regardless of the level or degree of injury, age or time elapsed from the SCI. In the course of follow-up three patients, initially classified as ASIA A, B and C, changed to ASIA B, C and D, respectively. In urodynamic studies, at the end of follow-up, 66.6% of the patients showed decrease in postmicturition residue and improvement in bladder compliance. At this time, neurop...Continue Reading
Citations
Oct 30, 2018·Stem Cells·Osahiko TsujiHideyuki Okano
Sep 13, 2019·Current Stem Cell Research & Therapy·Jinxuan RenLina Yu
Dec 13, 2019·Neurochemical Research·Ladislava VymetalovaSerhiy Forostyak
Jul 24, 2020·Neurorehabilitation and Neural Repair·Armin CurtRaphael Guzman
Sep 29, 2020·Neural Regeneration Research·Xu-Chang HuShuai Xing
Aug 9, 2020·Frontiers in Cell and Developmental Biology·Matthew H ForsbergChristian M Capitini
Sep 29, 2020·Cell & Bioscience·Ling Ling LiauJia Xian Law
Aug 17, 2019·Frontiers in Immunology·Henry CaplanCharles S Cox
Aug 1, 2020·Stem Cells International·Muhammad Najib Fathi Bin HassanJia Xian Law
Oct 19, 2019·Tissue Engineering and Regenerative Medicine·Mari Paz QuesadaSalvador Martínez
Jun 6, 2020·International Journal of Molecular Sciences·Kazuyoshi YamazakiKiyohiro Houkin
Nov 16, 2020·Life Sciences·Gisele Graça Leite Dos SantosCristiane Flora Villarreal
Nov 22, 2020·Cytotherapy·Yang YangLi-Min Rong
Jan 19, 2021·Stem Cells International·Meichen LiuJinlan Jiang
Feb 25, 2021·Cell & Bioscience·Nan AnMeiying Li
Mar 9, 2021·Journal of UOEH·Akira Ootsuyama
Mar 13, 2021·World Journal of Stem Cells·Pavan S UpadhyayulaJoseph D Ciacci
Mar 23, 2021·Experimental Neurology·Jonathon Chon Teng ChioMichael G Fehlings
Apr 4, 2021·Biology·Louis D V JohnsonWilliam E B Johnson
Jun 3, 2021·International Journal of Molecular Sciences·Pablo BonillaVictoria Moreno-Manzano
Jul 3, 2021·Biomedicines·Celia Bonilla, Mercedes Zurita
Jul 25, 2021·International Journal of Molecular Sciences·Hidenori Suzuki, Takashi Sakai
Aug 29, 2021·Pharmaceutics·Takeo MukaiTokiko Nagamura-Inoue